These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 20005901

  • 21. The role of tissue transglutaminase (TG2) in regulating the tumour progression of the mouse colon carcinoma CT26.
    Kotsakis P, Wang Z, Collighan RJ, Griffin M.
    Amino Acids; 2011 Oct; 41(4):909-21. PubMed ID: 21046178
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Tissue transglutaminase-mediated chemoresistance in cancer cells.
    Verma A, Mehta K.
    Drug Resist Updat; 2007 Oct; 10(4-5):144-51. PubMed ID: 17662645
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize.
    Korponay-Szabó IR, Vecsei Z, Király R, Dahlbom I, Chirdo F, Nemes E, Fésüs L, Mäki M.
    J Pediatr Gastroenterol Nutr; 2008 Mar; 46(3):253-61. PubMed ID: 18376241
    [Abstract] [Full Text] [Related]

  • 27. Phosphorylation of transglutaminase 2 by PKA at Ser216 creates 14-3-3 binding sites.
    Mishra S, Murphy LJ.
    Biochem Biophys Res Commun; 2006 Sep 08; 347(4):1166-70. PubMed ID: 16870138
    [Abstract] [Full Text] [Related]

  • 28. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
    Sarang Z, Molnár P, Németh T, Gomba S, Kardon T, Melino G, Cotecchia S, Fésüs L, Szondy Z.
    Hepatology; 2005 Sep 08; 42(3):578-87. PubMed ID: 16108039
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Tissue transglutaminase-mediated formation and cleavage of histamine-gliadin complexes: biological effects and implications for celiac disease.
    Qiao SW, Piper J, Haraldsen G, Oynebråten I, Fleckenstein B, Molberg O, Khosla C, Sollid LM.
    J Immunol; 2005 Feb 01; 174(3):1657-63. PubMed ID: 15661929
    [Abstract] [Full Text] [Related]

  • 32. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells.
    Ráki M, Tollefsen S, Molberg Ø, Lundin KE, Sollid LM, Jahnsen FL.
    Gastroenterology; 2006 Aug 01; 131(2):428-38. PubMed ID: 16890596
    [Abstract] [Full Text] [Related]

  • 33. Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl2 as detoxifiers.
    Engstrom N, Saenz-Méndez P, Scheers J, Scheers N.
    Sci Rep; 2017 Mar 06; 7(1):77. PubMed ID: 28250436
    [Abstract] [Full Text] [Related]

  • 34. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
    Bodey B, Bodey B, Kaiser HE.
    In Vivo; 1997 Mar 06; 11(4):351-70. PubMed ID: 9292303
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.
    Molberg O, McAdam S, Lundin KE, Kristiansen C, Arentz-Hansen H, Kett K, Sollid LM.
    Eur J Immunol; 2001 May 06; 31(5):1317-23. PubMed ID: 11465088
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Constitutive Differential Features of Type 2 Transglutaminase in Cells Derived from Celiac Patients and from Healthy Subjects.
    Paolella G, Nanayakkara M, Sposito S, Lepretti M, Auricchio S, Esposito C, Barone MV, Martucciello S, Caputo I.
    Int J Mol Sci; 2020 Feb 12; 21(4):. PubMed ID: 32059410
    [Abstract] [Full Text] [Related]

  • 39. Anti-idiotypic response in mice expressing human autoantibodies.
    Di Niro R, Sblattero D, Florian F, Stebel M, Zentilin L, Giacca M, Villanacci V, Galletti A, Not T, Ventura A, Marzari R.
    Mol Immunol; 2008 Mar 12; 45(6):1782-91. PubMed ID: 17996305
    [Abstract] [Full Text] [Related]

  • 40. Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement.
    Strnad P, Harada M, Siegel M, Terkeltaub RA, Graham RM, Khosla C, Omary MB.
    Gastroenterology; 2007 Apr 12; 132(4):1515-26. PubMed ID: 17408647
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.